Research output
- 1 Article
-
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Ghanem, R., Stegemann, M., Klein, K., Pammer, M., Rauscher, I., Salzer, H., Doppler, S., Habringer, A., Paar, C., Kimeswenger, S., Hoetzenecker, W., Lamprecht, B., Lee, S. & Schmitt, C., 13 Sept 2021, In: Cancer Cell. 39, 9, p. 1171-1172 2 p.Research output: Contribution to journal › Article › peer-review
-
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (ARGX-113-2402)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
04.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Phase III randomized, open-label, international, multicenter study evaluating the efficacy and safety of mosunetuzumab plus lenalidomide in comparison to anti- CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma (MorningLyte)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
02.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
AGMT Metastasic Colorectal Cancer Registry (mCRC) Third Line and Beyond (mCRC Registry)
Krivic, D. (Researcher), Piringer, G. (PI), Lichtenauer, N. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
20.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery (MK-2870-012)
Krivic, D. (Researcher), Preuß, C. I. (PI), Schwarz, H. K. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher), Trathnigg, N. (Researcher) & Lichtenauer, N. (Researcher)
18.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation
Ghanem, R. (Researcher), Kausche, L. E. (Researcher), Klein, K. (Researcher), Kovacsova, J. (Researcher), Krenosz, K. J. (Researcher), Krivic, D. (Researcher), Kühr, T. (Researcher), Popp, H. D. (Researcher), Schmitt, C. (Researcher), Schneeweiß, B. (Researcher), Schwarz, H. (Researcher), Stefan, A. (Researcher), Stegemann, M. (Researcher) & Piringer, G. (PI)
12.11.2024 → 31.12.2027
Project: Clinical studies › Clinical Study (Industry project)
-
Cerebral Toxoplasmosis: Pitfalls and spectrum of diagnostics in B-cell lymphoma. A case series
Klein, K. (Contributor)
12 Mar 2025 → 14 Mar 2025Activity: Talk or presentation › Poster presentation › science-to-science
-
Cerebrale Raumforderung bei peripherem B-Zell Lymphom
Klein, K. (Speaker)
17 Jan 2025Activity: Talk or presentation › Invited talk › science-to-science